Comparative effectiveness research (CER) is the concept of evaluating evidence on the relative medical benefits and costs of various treatments to identify the most effective one for any given diagnosis. The NHC has advocated for conducting CER in a way that is transparent and involves input from the patient community during every step of the process. CER has the potential to improve health outcomes by helping people make better-informed decisions. The National Health Council and Avalere Health prepared a white paper that outlines the research and discussion to create a framework to guide the development of CER, evaluate its results, and assist in communicating the findings to the right audiences.
- The National Pharmaceutical Council highlighted September's usability symposium in its October newsletter. The article includes interviews with speakers from the event, including NHC CEO Myrl Weinberg (October 30, 2013)
- Dr. D. Daniel Mullins, professor at the University of Maryland School of Pharmacy, delivered the keynote presentation during a National Health Council and National Pharmaceutical Council sponsored symposium on usability and Comparative Effectiveness Research (September 30, 2013)
- NHC CEO Myrl Weinberg talks about working with patients to develop usability criteria for Comparative Effectiveness Research (September 30, 2013)